Last reviewed · How we verify

NCT04761250

The Effect of a Multimodal Lifestyle Program on Male Fertility

Completed NA Last updated 27 September 2022
What this trial tests

NA trial testing Lifestyle in Infertility, Male in 26 participants. Completed in 12 September 2022.

Timeline
15 February 2021
Primary endpoint
1 June 2022
12 September 2022

Quick facts

Lead sponsorPeter Humaidan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment26
Start date15 February 2021
Primary completion1 June 2022
Estimated completion12 September 2022
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Peter Humaidan — full company profile →

Who can join

18 and older, male only, with Infertility, Male. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A non-pharmacological study, which examines the effect of lifestyle intervention on sperm quality among men in fertility treatment. The primary endpoint is to increase the total amount of motile sperm in male patients undergoing fertility treatment

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lifestyle

Trials testing the same drug.

Other recruiting trials for Infertility, Male

Currently open trials in the same condition.

Other Peter Humaidan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04761250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing